Styrene

Styrene

SCHEMBL782095

C=CC=C.C=Cc1ccccc1.c1ccncc1

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.64
TSHR P16473 2/20 0.64
CYP11B2 P19099 4/20 0.43
CYP11B1 P15538 1/20 0.43
TDP1 Q9NUW8 2/20 0.41
NAPRT Q6XQN6 1/20 0.41
CYP19A1 P11511 3/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37
NOTUM Q6P988 1/20 0.37
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.34
HDAC8 Q9BY41 2/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP1B1 Q16678 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Styrene SCHEMBL28482779 1.00 ALDH1A1 (0.64) ALDH1A1TSHRCYP11B2CYP11B1TDP1
Styrene SCHEMBL29055515 1.00 ALDH1A1 (0.64) ALDH1A1TSHRCYP11B2CYP11B1TDP1
Styrene SCHEMBL28278906 0.98 ALDH1A1 (0.61) ALDH1A1TSHRCYP11B2CYP11B1TDP1
Styrene SCHEMBL5179653 0.95 ALDH1A1 (0.70) ALDH1A1TSHRCYP11B2CYP11B1TDP1
Styrene SCHEMBL30014512 0.95 ALDH1A1 (0.70) ALDH1A1TSHRCYP11B2CYP11B1TDP1
Styrene SCHEMBL28358776 0.93 ALDH1A1 (0.67) ALDH1A1TSHRCYP11B2CYP11B1TDP1
Styrene SCHEMBL28265965 0.93 ALDH1A1 (0.67) ALDH1A1TSHRCYP11B2CYP11B1TDP1
Styrene SCHEMBL28032514 0.93 ALDH1A1 (0.67) ALDH1A1TSHRCYP11B2CYP11B1TDP1
Styrene SCHEMBL11490854 0.93 ALDH1A1 (0.67) ALDH1A1TSHRCYP11B2CYP11B1TDP1
Styrene SCHEMBL7601904 0.91 ALDH1A1 (0.64) ALDH1A1TSHRCYP11B2CYP11B1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 339 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4397806-A1 ENVIRONMENTALLY FRIENDLY IMPREGNATION SYSTEM FOR FIBER SURFACE TREATMENT, AND PREPARATION METHOD AND IMPREGNATION TREATMENT METHOD THEREFOR Beijing University Of Chemical Technology (CN) 2024-07-10 EP claimed
CN-117995459-A Graphene-coated superfine fully-vulcanized powder rubber composite microsphere as well as preparation method and application thereof 中国石油化工股份有限公司 2024-05-07 CN claimed
CN-117988118-A Composition for fiber surface treatment and fiber treatment method 北京化工大学 2024-05-07 CN claimed
CN-117839449-A High-flux high-pressure-resistant composite nanofiltration membrane and preparation method thereof 万华化学集团股份有限公司 2024-04-09 CN claimed
CN-117801167-A Preparation method and application of cycloparaffin modified styrene-butadiene-pyridine latex 江苏亚泰化工有限公司 2024-04-02 CN claimed
CN-117779473-A Dipping solution for fiber framework material 海利得新材料研究(上海)有限公司 2024-03-29 CN claimed
CN-117779476-A Non-phenolic type environment-friendly dipping solution for fiber framework material 海利得新材料研究(上海)有限公司 2024-03-29 CN claimed
CN-117779453-A Non-phenolic type environment-friendly dipping solution of fiber framework material 海利得新材料研究(上海)有限公司 2024-03-29 CN claimed
CN-117721640-A Dipping solution and preparation method thereof, and dipping method of fiber curtain cloth 太原理工大学 2024-03-19 CN claimed
CN-115304758-B Sulfur-containing polyester based on orcinol derivative, preparation and application 深圳万知达技术转移中心有限公司 2024-03-01 CN claimed
US-8481619-B2 Aqueous resorcinol-formaldehyde-latex dispersions, adhesion-improved fibres, processes for production thereof and use thereof RHEIN CHEMIE RHEINAU GMBH (US) 2013-07-09 US claimed
US-20120123029-A1 Novel aqueous resorcinol-formaldehyde-latex dispersions, a process for production of the said dispersions and use of the said dispersions RHEIN CHEMIE RHEINAU GMBH (DE) 2012-05-17 US claimed
CN-101638453-B Modified pyridine styrene butadiene rubber latex and preparation method and application thereof JINGDONG YU 2012-05-09 CN claimed
US-20120100290-A1 Novel bonding agents based on carbodiimides, aqueous resorcinol-formaldehyde-latex dispersions comprising bonding agent, adhesion-improved fibres, processes for production thereof and use thereof RHEIN CHEMIE RHEINAU GMBH (DE) 2012-04-26 US claimed
US-20120071595-A1 Novel aqueous resorcinol-formaldehyde-latex dispersions, adhesion-improved fibres, processes for production thereof and use thereof RHEIN CHEMIE RHEINAU GMBH (DE) 2012-03-22 US claimed
CN-101638453-A Modified pyridine styrene butadiene rubber latex and preparation method and application thereof JINGDONG YU 2010-02-03 CN claimed
EP-1349889-B1 METHOD FOR THE PRODUCTION OF A CARBON FIBRE-BASED REINFORCING ELEMENT FOR TYRES SOVOUTRI SOC VOULTAINE DE TRAN (FR) 2006-07-26 EP claimed
JP-2004522867-A 2004-07-29 JP claimed
EP-1349889-A1 METHOD FOR THE PRODUCTION OF A CARBON FIBRE-BASED REINFORCING ELEMENT FOR TYRES Sovoutri Société Voultaine de Transformes Industriels (FR) 2003-10-08 EP claimed
WO-2002055590-A1 METHOD FOR THE PRODUCTION OF A CARBON FIBRE-BASED REINFORCING ELEMENT FOR TYRES SOVOUTRI SOCIETE VOULTAINE DE TRANSFORMES INDUSTRIELS (FR) 2002-07-18 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120100290-A1 Novel bonding agents based on carbodiimides, aqueous resorcinol-formaldehyde-latex dispersions comprising bonding agent, adhesion-improved fibres, processes for production thereof and use thereof VIM, TYR, DDT ALDH1A1 664/4885TSHR 2820/4885CYP11B2 4595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.